Bausch Health Companies BHC
NYSE BHC
$6.82 -0.07 (-1.09%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2026)

Bausch Health Companies (BHC) posted Asset Writedowns and Impairment of $9.0 million for Q2 2026, up 28.57% sequentially from $7.0 million in Q4 2025.

Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2026) Analysis & Trends

Bausch Health Companies has reported Asset Writedowns and Impairment for 13 years, with the latest figure at $9.0 million in Q2 2026.

  • Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $9.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $17.0 million (down 26.09% YoY) and the FY2025 annual result came in at $8.0 million, down 72.41% from the prior year.
  • Asset Writedowns and Impairment grew to $9.0 million in Q2 2026 per BHC's latest filing, from $7.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $37.0 million in Q2 2023 and troughed at $1.0 million in Q3 2022.
  • A 5-year average of $9.6 million and a median of $6.5 million in 2022 frame the typical range for Asset Writedowns and Impairment.
  • The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment sank 94.59% in 2022, then jumped 516.67% in 2023.
  • Over 5 years, Asset Writedowns and Impairment stood at $1.0 million in 2022, then jumped by 300.0% to $4.0 million in 2023, then soared by 475.0% to $23.0 million in 2024, then tumbled by 69.57% to $7.0 million in 2025, then gained by 28.57% to $9.0 million in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $9.0 million, $7.0 million, and $1.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Bausch Health Companies 2.56 Bn 725.13 Mn 2.10 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 9.00 Mn
Jun 30, 2026 9.00 Mn
Dec 31, 2025 7.00 Mn
Dec 31, 2025 7.00 Mn
Sep 30, 2025 1.00 Mn
Sep 30, 2025 1.00 Mn
Dec 31, 2024 23.00 Mn
Dec 31, 2024 23.00 Mn
Jun 30, 2024 5.00 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 1.00 Mn
Mar 31, 2024 1.00 Mn
Sep 30, 2023 4.00 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 37.00 Mn
Jun 30, 2023 37.00 Mn
Mar 31, 2023 13.00 Mn
Mar 31, 2023 13.00 Mn
Sep 30, 2022 1.00 Mn
Sep 30, 2022 1.00 Mn